trial · primary record
ABP-671 plus febuxostat Group 1
Chronic Kidney Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2028-01-31 |
| Primary endpoint | The change in the urine albumin-to-creatinine ratio (mg/g) as reported in the laboratory report compared to the baseline |
| Registry ID | NCT07323095 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:46.061Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07323095
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.